| Market Cap | €732.3M | |
| Enterprise Value | — | |
| Revenue | €4.5M | −51.3% |
| Gross Profit | — | — |
| EBITDA | — | — |
| Net Income | -€354.1M | — |
| Diluted EPS | -€1.90 | — |
| Free Cash Flow | — | — |
| Ratio | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Trend · 7y | vs own |
|---|---|---|---|---|---|---|---|---|---|
| ▾Margins | |||||||||
| Operating Margin | −433.15% | −7988.71% | −1242.58% | −468.92% | −587.68% | −1060.64% | −3145.51% | 21% | |
| Net Margin | −431.81% | −9037.37% | −1183.48% | −445.64% | −631.84% | −2002.74% | −7899.58% | 21% | |
| OCF Margin | −405.89% | −8223.12% | −1135.65% | −368.90% | −466.98% | −934.20% | −2339.59% | 21% | |
| ▸Returns on Capital · 3 ratios | |||||||||
| ▸DuPont factors (ROE drivers) · 2 ratios | |||||||||
| ▸Earnings quality · 2 ratios | |||||||||
| ▸Liquidity & coverage · 5 ratios | |||||||||
| ▸Leverage · 8 ratios | |||||||||
| ▸Working capital · 3 ratios | |||||||||
| ▸Per share · 2 ratios | |||||||||
| ▸Other · 1 ratios | |||||||||
| Line | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | €7.0M | €372,000 | €4.2M | €12.2M | €17.5M | €9.2M | €4.5M |
| YoY % | -94.7% | +1027.4% | +190.4% | +43.5% | -47.4% | -51.3% | |
| R&D Expense | €33.8M | €23.7M | €48.5M | €60.5M | €110.0M | €90.9M | €87.0M |
| YoY % | -29.8% | +104.3% | +24.8% | +81.9% | -17.4% | -4.2% | |
| Selling & Marketing Expense | €249,000 | €563,000 | €364,000 | €2.6M | €2.0M | €2.0M | €5.0M |
| YoY % | +126.1% | -35.3% | +609.6% | -23.3% | -1.4% | +154.1% | |
| SG&A Expense | €6.1M | €8.5M | €11.2M | €12.9M | €13.8M | €15.8M | €47.9M |
| YoY % | +39.6% | +31.3% | +15.8% | +7.2% | +14.5% | +202.4% | |
| Operating Income | -€30.3M | -€29.7M | -€52.1M | -€57.1M | -€102.7M | -€97.6M | -€141.0M |
| Interest Expense | €81,000 | €6.0M | €2.6M | €2.1M | €6.9M | €88.9M | €216.9M |
| YoY % | +7256.8% | -55.8% | -20.0% | +226.6% | +1192.0% | +144.0% | |
| Interest & Investment Income | €175,000 | €2.1M | €5.5M | €4.9M | €1.8M | €2.9M | €4.2M |
| YoY % | +1075.4% | +166.3% | -10.1% | -63.7% | +61.5% | +44.4% | |
| Equity Method Income | — | — | €0 | €0 | -€2.0M | -€313,000 | -€350,000 |
| Income Tax | €0 | €0 | €364,000 | -€20,000 | €607,000 | €313,000 | €22,000 |
| YoY % | -48.4% | -93.0% | |||||
| Net Income (incl. NCI) | -€30.2M | -€33.6M | -€49.6M | -€54.3M | -€110.4M | -€184.2M | -€354.1M |
| EPS (Basic) | — | -€0.99 | -€1.27 | -€1.31 | -€2.43 | -€3.08 | -€1.90 |
| EPS (Diluted) | — | -€0.99 | -€1.27 | -€1.31 | -€2.43 | -€3.08 | -€1.90 |
| Weighted Avg Shares (Basic) | — | — | 39.2M | 41.4M | 45.4M | 59.8M | 186.8M |
| YoY % | +5.8% | +9.4% | +31.8% | +212.5% | |||
| Weighted Avg Shares (Diluted) | 23.5M | 33.9M | 39.2M | 41.4M | 45.4M | 59.8M | 186.8M |
| YoY % | +44.0% | +15.6% | +5.8% | +9.4% | +31.8% | +212.5% |
Statement lines are XBRL facts as filed with the company's home regulator (SEC EDGAR for US filers; ESEF/EDINET and other national regulators for foreign filers); ratios and other derived figures are computed from them. A blank cell means the tag was absent — never imputed.
